Clinical Trial Update: Placebo Controlled Evaluation of Sedation and Physiological Response to Intranasal Dexmedetomidine in Severe COPD [Phase 4]

View source ↗

Summary

This update notes that the Phase 4 placebo-controlled trial evaluating intranasal dexmedetomidine for sedation and physiological response in severe COPD has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Dayton VA Medical Center | Conditions: COPD | Phase 4 | Status: WITHDRAWN